Vera Therapeutics, Inc. (VERA): Shareholders' Equity
$604.52M
As of 2025-12-31
$407.76M
As of 2026-06-30
+98.8%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $604.52M | +4.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $577.15M | +467.6% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $101.69M | +32.2% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $76.91M | +10.5% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $69.59M | n/m | 2023-03-28, Balance as of period end |
| 2020-12-31 | -$89.35M | n/a | 2022-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | 2025-12-31 | $604.52M | +4.7% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $174.13M | -57.9% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $364.05M | -13.6% |
| Summit Therapeutics Inc. (SMMT) | 2025-12-31 | $658.86M | +69.5% |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2025-12-31 | $581.33M | +54.0% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $433.90M | -22.8% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $609.98M | -23.1% |
| Viking Therapeutics, Inc. (VKTX) | 2025-12-31 | $639.06M | -27.4% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $567.61M | +29.5% |
Compare VERA, KURA, SDGR, SMMT side by side · Screen every company in Pharmaceutical Preparations ↗